Clinical Trial Update: Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating sunitinib malate as maintenance therapy after chemotherapy in stage IIIB/IV non-small cell lung cancer; study completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Stage Iiib Non-small Cell Lung Cancer

Drugs mentioned

• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IIIB Lung Non-Small Cell Cancer AJCC v7, Stage IV Non-Small Cell Lung Cancer AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2017-02-02